We read with interest the recently published article by Seah et al. [1]. While we agree with the authors that infectious risk is highest in ophthalmology clinic settings, we would like to discuss the precautions for virus transmission in amniotic membrane harvest and share our experience amidst the COVID-19 pandemic.

Most elective surgeries have been suspended globally to mitigate the spread of COVID-19. However, the expiry date of our stock of amniotic membrane coincided with the local COVID-19 outbreak in February 2020. Furthermore, local distributors of dehydrated amniotic membrane also encountered a delay in shipment. Meanwhile, we had two cases of Stevens Johnson Syndrome with total conjunctival epithelial defects requiring urgent amniotic membrane transplant. In view of this, we proceeded to amniotic membrane harvest according to the standard protocol [2] but adopted extra infection control measures.

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account
Continue with Google
Continue with ORCiD